PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical") announces that based on subscriptions received to date, the Company expects that its $4,000,000 non-brokered private placement (the "Offering") of units at $0.05 (post-forward stock split) announced on April 9, 2018, will be oversubscribed due to higher than expected investor interest.
The post PreveCeutical Announces Oversubscribed Non-Brokered Private Placement appeared first on Investing News Network.
Original Article: PreveCeutical Announces Oversubscribed Non-Brokered Private Placement